effective and precision therapies are constantly sought as treatment options for the continuously rising number of patients with both periodontal disease and osteoporosis.
A variety of treatment options for periodontal bone defects healing have been proposed using novel tissue engineering scaffolds. 4 In recent years, mesoporous bioactive glass (MBG) has been utilized as a bioactive material with pore sizes ranging from 5 to 20 nm and a well-ordered mesoporous channel structure capable of promoting new bone formation in vivo. [5] [6] [7] [8] Strontium Ranelate has been applied clinically to prevent osteoporosis and strontium has been shown to activate calcium sensing receptor (CaSR) and downstream protein phosphorylation to promote osteogenesis. 9 Recently our group developed a kind of MBG scaffold containing strontium and demonstrates its positive effective on promoting osteogenesis and periodontal regeneration in osteoporotic animal models. [10] [11] [12] Although strontium ions play an important role by inhibiting bone resorption and promoting bone formation through different signaling pathways, 13, 14 the mechanism in the nucleus at the genetic level during periodontal regeneration stimulated by Sr ions remains unclear.
Alternative splicing is a kind of the regulatory mechanism in eukaryotic cells, whereby the pre-mRNA can be spliced into multiple mature mRNA due to the introns existing in the DNA, followed by translation to produce a variety of proteins. 15, 16 HnRNPL is an important member in the family of ribonucleic protein splicing factors enriched in cell nucleus and plays an important role in many physiological and pathological processes. 17, 18 HnRNPL contains four RRM domains, a proline-rich sequence separating RRMs 2 and 3 and a glycine-rich N-terminal domain. 19 This ubiquitous splicing-regulatory protein is critical for the oncogenesis such as osteosarcoma and the development of T cells. 20 It can also inhibit P53 to prevent DNA damage-induced apoptosis in embryonic stem cells. 21 Moreover, cluster analysis of genes regulated by hnRNPL showed genes containing hn-RNPL-regulated exons were associated with chromatin regulation, DNA modification and transcription, implied the epigenetic role in hnRNPL-related splicing process. 22 
HnRNPL can interact with Set2
and is related to the retention of introns in eukaryotic cells. 22 We have previously shown the positive regulation of Setd2 in the process of osteogenesis stimulated by Sr. 23 However, whether hnRNPL can regulate the osteogenesis process is still lack of evidence.
In this study, we demonstrated that hnRNPL could play a role in the osteogenic differentiation of PDLCs stimulated by Sr by regulating Setd2. Following stimulation with Sr, the AKT pathway was activated and then repressed the expression of splicing factor hn-RNPL, ultimately promoted the osteogenic differentiation of PDLCs through Setd2 up-regulation.
| MATERIAL S AND ME THODS

| Preparation of MBG and Sr-MBG scaffolds
Preparation and characterization of Sr-MBG scaffolds were performed as previous described. 24 Porous strontium-incorporated mesopore-bioglass (Sr-MBG) scaffolds were prepared by incorporating different contents of Sr (molar: 5%) into MBG using cotemplates of nonionic block polymer P123 (EO20-PO70-EO20) and polyurethane sponges. In brief, to prepare MBG scaffolds contain- 
| Animals and surgical procedures
Establishment of the osteoporotic rat models were performed as previous described 12, 24, 25 in accordance with the policies of Two months after the osteoporosis model was established, periodontal fenestration defects (standardized with 2.8 mm in length,
1.4 mm in height and 0.5 mm in depth) were created as previous described. 12 Briefly, under general anesthesia, rats were subjected to bilateral extra-oral incision at the base of the mandible. The buccal mandibular bone overlying the first molar roots was removed to create a defect (2.8 mm in length, 1.4 mm in height and <0.5 mm in depth) using a size-4 round bur. The procedure was performed under an operating microscope to avoid perforation of intraoral mucosa.
The roots of the first molar were carefully denuded of their periodontal ligament, overlying cementum, and superficial dentin. The height was standardized to the width of the round bur (diameter 1.4 mm) and extended longitudinally to either side. Then, two scaffolds were gently implanted respectively into the bilateral periodontal fenestration defects (MBG in the left and Sr-MBG in the right defect). Following implantation of scaffolds, the muscle and the skin were repositioned and sutured separately. Postoperatively, penicillin (40,000 IU/mL, 1 mL/kg) was injected intramuscularly for 3 days.
Four weeks after surgery, the rats were sacrificed by sodium pentobarbital, following a protocol approved by the Institutional Animal
Care and Use Committee (IACUC).
| Immuno-histochemical staining
The immune-histochemical staining was performed as previous described. 23 Periodontal bone regeneration samples were immersed in 10% EDTA changed twice weekly for 3 weeks until decalcifica- 
| Isolation and culture of human PDLCs
Human PDL cells were cultured in α-MEM medium (Hyclone, Thermo
Fisher Scientific Inc., New York, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, Life Technologies Corporation) and 100 U/mL penicillin G and 100 mg/mL streptomycin (HyClone) at 37°C with 5% CO 2 . Osteogenic inducing medium comprised α-MEM containing 10% FBS, 100 U/mL penicillin and 100 mg/mL strepto-
50 μg/mL L-ascorbic acid and different concentrations of SrCl2 (0, 0.01, 0.1, 1, 3 mmol/L). Primary PDLCs were seeded from passages 4-6 at a density of 5000/well in 96-well culture plates for cell proliferation experiments and 300 000/well in 6-well culture plates for real-time PCR and alizarin red experiments. For experiments lasting longer than 5 days, medium was replaced with fresh one twice weekly.
| Viral transfection
Viral packaging and transfection was performed as previously described. 26 The target sequences for shRNA1 were: hnRNPL of humans:
5′-CGACAACCAAATATACATT-3′; The target sequences for shRNA1
were: hnRNPL of humans: 5′-CTTGAATGTGTTCAAGAAT-3′; Setd2 of humans: 5′-TAGTACACCAAGACTCCAG-3′. pHAGE-HA-SETD2
plasmid was available from Dr Min Wu (Wuhan University). The overexpression plasmid or shRNA plasmid, as well as two helper vectors (pMD2G and pSPAX2) were transfected into HEK293T cells using Neofect transfection reagent. The viral supernatants were collected after 48 hours and then concentrated. The supernatants were then used to transfect PDLCs in the presence of 10 μg/mL polybrene (Sigma). Twenty-four hours later, the viral supernatants were removed and cultured with fresh growth medium.
| Alizarin red staining and quantification
Alizarin red staining was performed to determine the presence of extracellular matrix mineralization in vitro. PDLCs were fixed in 4%
formaldehyde for 15 minutes after culture for 21 days and stained with 0.01% alizarin red solution (pH 4.2) at room temperature for 1 hours. For quantifying the relative amount of calcium, the stained nodes were dissolved using 200 μl of 1% cetylpyridinium chloride (Sigma, USA) per well at room temperature for 4 hours and then the OD value was measured at 560 nm.
| ALP staining and quantification
PDLCs were fixed in 4% formaldehyde for 15 minutes after being cultured for 7, 14 and 21 days and stained with ALP staining kit (Beyotime Biotechnology, China) at 37°C for 30 minutes.
| Protein extraction and western blotting
Protein extraction and western blotting was performed as previously described. 26 PDLCs were starved for 24 hours, then stimulated by SrCl 2 , collected with PBS, mixed with loading buffer and then heated at 95°C for 10 minutes for total protein denaturation. Nuclear and cytoplasmic proteins were extracted by Nuclear and Cytoplasmic
Protein Extraction Kit (Beyotime Biotechnology, China). The protein contents were determined by using a bicinchoninic acid (BCA) assay kit (Thermo Scientific).
Proteins were separated by SDS-PAGE then transferred to nitrocellulose membranes. The membranes were blocked using 5% non-fat milk or 5% BSA for 60 minutes at room temperature.
Membranes were incubated with primary antibodies against hnRNPL (1:1000), Setd2 (1:1000), H3K36me3, P-AKT (1:2000), AKT(1:1000), P-CREB (1:2000) at 4°C overnight, followed by secondary antibodies for 1 hours at room temperature. Protein bands on the membranes were visualized using Western Bright ECL HRP substrate Kit (Advansta).
| RNA extraction and RT-qPCR
Total RNA was extracted with Trizol reagent (TriPure Isolation Reagent, Roche Applied Science, Germany) according to the manufacturer's instructions. The concentration and quality of the total RNA samples were measured using Nanodrop2000 (Thermo Scientific). Complementary DNA was synthesized from 1 μg of total RNA using PrimeScript RT-PCR Kit (TaKaRa, Japan) following the manufacturer's protocol. RT-qPCR was performed with
PrimeScript RT-PCR Kit (TaKaRa, Japan). The primers are shown in Table 1 .
| Statistical analysis
GraphPad Prism software (GraphPad, San Diego, CA) was used for the statistical analyses. Two-way ANOVA and Students′ t test was used to assess differences between the control and test groups. P-values less than 0.05 were considered statistically significant.
| RE SULTS
| MBG scaffolds containing Sr promotes periodontal regeneration whereas represses hnRNPL expression
Firstly, the effect of Sr-MBG scaffolds on periodontal regenera- Figure 2B,D) . Then we suspected if this effect was due to the proliferation of PDLCs, whereas the results showed no effect of the concentration of SrCl 2 on the proliferation of PDLCs ( Figure 2F ).
| SrCl 2 promotes PDLCs osteogenic differentiation through AKT pathway
Strontium was shown to activate calcium sensing receptor (CaSR) and downstream protein phosphorylation and to promote osteogenesis. 9 AKT is one of the most important protein kinases downstream of CaSR. Furthermore, AKT pathway was involved in Sr induced osteogenesis and angiogenesis. 27 Therefore, we investigated the 
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Reverse 5′-TCTGGGTGGCAGTGATGGC-3′ 1 hour both in the nucleus and cytoplasm ( Figure 3A-C) . CREB, the downstream protein of the AKT pathway, was also phosphorylated at 15 minutes after SrCl 2 stimulation ( Figure 3C ). Moreover, PDLCs pretreated by AKT specific inhibitors MK2206 failed to form similar mineralized nodes compared to the normal PDLCs with Sr stimulation ( Figure 3D-FC) , indicated the positive role of AKT pathway in the differentiation process stimulated by Sr.
| HnRNPL represses PDLCs osteogenic differentiation stimulated by Sr
Since hnRNPL was expressed in low levels in the Sr-MBG group in vivo, we then examined the expression of hnRNPL in PDLCs.
Western blot results showed hnRNPL was significantly decreased 
| HnRNPL can inhibit the expression of Setd2 to suppress PDLCs osteogenic differentiation stimulated by Sr
Setd2-mediated H3K36me3 has also previously been shown to be involved in the regulation of alternative splicing, 28 but whether it is associated with the splicing process mediated by hnRNPL is remained unknown. Immunohistochemistry results showed that the (F) Quantification of alizarin red staining. *P < 0.5; **P < 0.01; ***P < 0.001 percentages of Setd2-positive and H3K36me3-positive cells are significantly higher in the group containing Sr in vivo ( Figure 1G-O) . It was revealed that the expression of Setd2 was significantly increased from 2 hours after SrCl 2 stimulation (time when hnRNPL decreased).
When pre-treated with the AKT inhibitor MK2206, the expression of Setd2 failed to be promoted by Sr in PDLCs ( Figure 3D ). More importantly, when hnRNPL was silenced, the expression of Setd2 was significantly increased in PDLCs, with the highest expression observed following Sr stimulation ( Figure 4I ). These results implied that the AKT pathway promoted Setd2 expression through repressing downstream hnRNPL.
However, whether Setd2 played a positive role similar to the AKT pathway remained unknown. We therefore investigated the role of Setd2 during Sr-induced osteogenic differentiation of PDLCs by Setd2 knock-down or over-expression ( Figure 5A,B) . The results
showed that mineralization, ALP activity and the expression of osteogenic-related markers ALP, Runx2 and OCN were decreased in the knock-down group in PDLCs even when stimulated with 
| D ISCUSS I ON
Periodontal tissue regeneration has been a major problem for clinicians for a long time, of which periodontal bone regeneration is the most important part. Periodontal tissues include gingiva, cementum, periodontium and alveolar bone. Osteoporosis is a disease characterized by reduced bone density, causes more complex treatment and poor prognosis of periodontal defects. 29 The molecular mechanisms underlying this bone condition are related to estrogen (G) Expression level of osteogenic genes, Runx2, ALP, OCN of PDLCs after Setd2 knockdown or over-expression and induction towards osteogenic differentiation with or without SrCl 2 stimulation. *P < 0.5; **P < 0.01; ***P < 0.001 deficiency and overproduction of some cytokines. 30 Strontium
Ranelate is believed to be effective in osteoporosis treatment, and many studies have confirmed that strontium ions can prevent osteoporosis by regulating osteoblasts and osteoclasts. In the treatment of periodontal tissue destruction, there is a need to discover key factors of bone metabolism as potential targets for the treatment and management osteoporosis.
Mesoporous bioactive glass (MBG) with well-ordered mesoporous channels has been shown to facilitate osteogenesis and bioactivity in vivo. [5] [6] [7] [8] 31 In addition, the ions and degradation products of MBG have been reported to effectively promote the expression of osteogenic genes and proteins. Various groups have now combined biomaterials with strontium (Sr) ions in order to improve their biological activity and osteogenic potential. 14, 32 Our research group recently demonstrated that the MBG scaffolds combined with Sr, efficiently promoted periodontal regeneration in rat periodontal fenestration defects even in severely osteoporotic animals. 10 In the present study, immunohistochemistry staining of Runx2 was performed to detect the early osteogenic differentiation ability of PDLCs around these biomaterials. The results showed that the larger proportion of Some previous studies demonstrated that several hnRNP family members changed significantly in BMSCs during osteogenesis and can regulate gene transcription and RNA splicing in bone metabolism. 35, 36 The change of hnRNPL expression after drug treatment in osteosarcoma cells indicates that hnRNPL was involved in the physiological activity of bone-related cells, 37 and the alternative splicing mediated by hnRNPL is associated with protein phosphorylation. 38 We therefore investigated the expression and effect of hnRNPL in
PDLCs during the osteogenic differentiation with Sr stimulation. The results showed a negative role of hnRNPL in this process and also suppressed by AKT pathway.
Recently one study showed histone H3K36 methylation affected alternative splicing in plants with H3K36me3 being involved in the regulation of alternative splicing. 28 The methylation of H3K36 was also proposed to be associated with osteogenesis. 39, 40 We then de- Setd2 by increasing the production and recruitment of inhibiting or repressor proteins to suppress the expression of Setd2.
In conclusion, we provide rational describing the role of hnRNPL and Setd2 during periodontal regeneration. It is therefore possible to target hnRNPL and Setd2 as potential novel therapeutic targets for the treatment of periodontal tissue destruction most notably in osteoporotic patients.
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